News
Article
Author(s):
Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
To stay informed with the latest conference insights, subscribe to receive our eNewsletters.
The TRACE study showed tralokinumab reduced genital AD severity and improved quality of life within 3 months of treatment.
Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.
Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.
Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.
The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.
To view all conference coverage from Elevate-Derm West 2024, click here.